Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives. 1998

R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
Departments of Medicinal Chemistry and Oncopharmacology, Sanofi Winthrop Inc., 9 Great Valley Parkway, Malvern, Pennsylvania 19355, USA.

Two new series of antitumor agents, 4-aminomethylthioxanthenones (6-50) and 5-aminomethylbenzothiopyranoindazoles (51-61), are described and compared. Nearly all members of both series display excellent in vivo activity versus murine pancreatic adenocarcinoma 03 (Panc03) although there is little to distinguish the two series from each other. In both series there is no discernible relationship between structure and in vivo efficacy. Selected analogues were evaluated in vitro; all were observed to have moderate to strong DNA binding via intercalation. However, varying degrees of in vitro P388 cytotoxicity and topoisomerase II inhibition were seen. In general, those molecules which exhibited strong topoisomerase II inhibition were significantly more cytotoxic than those which did not. In both series, those derivatives (48-50, 60, and 61) having a phenolic hydroxy substitution exhibited the most potent P388 cytotoxicity and topoisomerase II inhibition.

UI MeSH Term Description Entries
D007191 Indazoles A group of heterocyclic aromatic organic compounds consisting of the fusion of BENZENE and PYRAZOLES. Indazole
D007364 Intercalating Agents Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA. Intercalating Agent,Intercalating Ligand,Intercalative Compound,Intercalator,Intercalators,Intercalating Ligands,Intercalative Compounds,Agent, Intercalating,Agents, Intercalating,Compound, Intercalative,Compounds, Intercalative,Ligand, Intercalating,Ligands, Intercalating
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D011714 Pyrans Pyran
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
January 1987, Journal of medicinal chemistry,
R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
November 2004, Bioorganic & medicinal chemistry letters,
R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
January 1996, Medicinal research reviews,
R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
July 1987, Journal of medicinal chemistry,
R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
August 1965, Gan,
R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
January 1992, Yao xue xue bao = Acta pharmaceutica Sinica,
R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
October 1995, Journal of medicinal chemistry,
R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
May 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
December 2005, Bioorganic & medicinal chemistry,
R B Perni, and M P Wentland, and J I Huang, and R G Powles, and S Aldous, and K M Klingbeil, and A D Peverly, and R G Robinson, and T H Corbett, and J L Jones, and K C Mattes, and J B Rake, and S A Coughlin
March 2010, Medicinal chemistry (Shariqah (United Arab Emirates)),
Copied contents to your clipboard!